E Fund Management Co. Ltd. Has $982,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

E Fund Management Co. Ltd. lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 14.4% in the fourth quarter, Holdings Channel.com reports. The fund owned 1,865 shares of the healthcare conglomerate’s stock after purchasing an additional 235 shares during the quarter. E Fund Management Co. Ltd.’s holdings in UnitedHealth Group were worth $982,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Pioneer Trust Bank N A OR grew its stake in shares of UnitedHealth Group by 3.0% in the fourth quarter. Pioneer Trust Bank N A OR now owns 25,139 shares of the healthcare conglomerate’s stock valued at $13,235,000 after buying an additional 734 shares in the last quarter. National Pension Service increased its position in shares of UnitedHealth Group by 1.9% in the fourth quarter. National Pension Service now owns 1,440,593 shares of the healthcare conglomerate’s stock worth $758,429,000 after purchasing an additional 27,533 shares during the period. Arlington Capital Management Inc. bought a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $702,000. Meridian Wealth Advisors LLC lifted its stake in UnitedHealth Group by 1.7% during the fourth quarter. Meridian Wealth Advisors LLC now owns 11,913 shares of the healthcare conglomerate’s stock worth $6,272,000 after purchasing an additional 199 shares during the last quarter. Finally, RMR Wealth Builders boosted its stake in UnitedHealth Group by 16.0% in the fourth quarter. RMR Wealth Builders now owns 2,682 shares of the healthcare conglomerate’s stock valued at $1,412,000 after buying an additional 370 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Activity

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH traded up $2.25 on Wednesday, hitting $503.21. The company had a trading volume of 2,922,430 shares, compared to its average volume of 4,362,104. The company has a market capitalization of $462.99 billion, a PE ratio of 30.76, a PEG ratio of 1.43 and a beta of 0.55. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company’s fifty day moving average price is $481.45 and its 200-day moving average price is $511.98. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.26 EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.49%. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several research reports. Bank of America restated a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Stephens reissued an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Piper Sandler upped their target price on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Finally, HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a research report on Thursday, April 4th. Four analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

View Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.